Empirical Null Hypothesis for EEG Epoch Similarity Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current EEG analysis methods face challenges in determining the similarity and comparability of different epochs in EEG recordings, leading to difficulties in identifying significant patterns or abnormalities such as seizures, due to the reliance on theoretical null hypothesis distributions which may not accurately represent real-world data.

Innovation Solution

The implementation of an empirical null hypothesis approach, which estimates a null density from large-scale data, allowing for the comparison of EEG epochs by establishing a baseline and measuring similarity using large-scale testing, thereby providing a more dispersed and realistic null distribution for identifying significant patterns.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If theoretical null hypothesis distributions are used for EEG epoch comparison, then the analysis method is simple and fast, but the accuracy of identifying significant patterns and abnormalities is reduced

Engineering Contradiction:
Improveaccuracy of identifying significant patternsVSAvoidcomplexity of null hypothesis estimation method
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent performs preliminary estimation of the empirical null distribution from a large baseline dataset before actual epoch comparison. This pre-computed empirical null hypothesis is then reused for multiple comparisons, avoiding repeated complex calculations while maintaining high accuracy in identifying significant patterns and abnormalities.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses a large-scale baseline dataset (excessive data) to estimate the empirical null distribution, which provides more accurate characterization of normal variability than minimal data would. This excessive sampling in the baseline phase improves the precision of subsequent epoch comparisons without increasing the complexity of the comparison algorithm itself.

Inventive Principle:
Principle #16Partial or excessive action

2Reliability

If theoretical null hypothesis distributions are used, then computational resources are conserved, but false positives increase and diagnostic accuracy decreases

Engineering Contradiction:
Improvereliability of epoch comparisonVSAvoidcomputational resources for null hypothesis testing
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The empirical null distribution is estimated once in advance from a large baseline dataset, and this pre-computed reference is then used for all subsequent epoch comparisons. This preliminary action shifts computational resources from repeated testing to a single comprehensive estimation, improving reliability while reducing overall computational burden.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If theoretical null hypothesis distributions are used for EEG analysis, then the method is easier to implement, but the ability to detect seizures and abnormalities is reduced

Engineering Contradiction:
Improvedetection accuracy of seizures and abnormalitiesVSAvoidease of implementation of analysis method
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent pre-computes the empirical null distribution from baseline data and stores it for reference during actual analysis. This preliminary estimation captures the true variability characteristics of the specific patient or population, significantly improving detection accuracy of seizures and abnormalities while keeping the implementation straightforward through template matching against the pre-computed empirical null.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS11457855B2Method and system for utilizing empirical null hypothesis for a biological time series
Publication Date: 2022.10.04 PERSYST DEVELOPMENT CORP
  • US11457855B2 patent drawing
  • US11457855B2 patent drawing
  • US11457855B2 patent drawing

AI summary

A method and system for utilizing empirical null hypothesis for a biological time series is disclosed herein. The method also includes calculating an amount that a second plurality of epochs is similar to a first plurality of epochs using large-scale testing to estimate an empirical null hypothesis for a subset of the epochs. The method also includes determining if the second plurality of epochs is from the same EEG recording.